New approval: Trastuzumab-deruxtecan for metastatic breast cancer HER2

xlomafota13 shared this article with you from Inoreader New approval: Trastuzumab-deruxtecan for metastatic breast cancer HER2 Via Association française pour l'étude du cancer Bull Cancer. 2021 Jun 15:S0007-4551(21)00212-5. doi: 10.1016/j.bulcan.2021.05.001. Online ahead of print. NO ABSTRACT PMID:34144792 | DOI:10.1016/j.bulcan.2021.05.001 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.